Pazopanib-d6
- Product NamePazopanib-d6
- CAS1219592-01-4
- CBNumberCB72741889
- MFC21H23N7O2S
- MW437.52
- MOL File1219592-01-4.mol
- MSDS FileSDS
Chemical Properties
| storage temp. | Store at -20°C |
| solubility | DMF: 16 mg/ml; DMSO: 16 mg/ml |
| form | A solid |
| color | White to off-white |
Pazopanib-d6 Price
| Product number | Packaging | Price | Product description | Buy |
|---|---|---|---|---|
| Cayman Chemical 25446 | 500μg | $319 | Pazopanib-d6 ≥99%deuteratedforms(d<sub>1</sub>-d<sub>6</sub>) |
Buy |
| Cayman Chemical 25446 | 1mg | $604 | Pazopanib-d6 ≥99%deuteratedforms(d<sub>1</sub>-d<sub>6</sub>) |
Buy |
| ChemScene CS-0078393 | 500??g | $303 | Pazopanib-d6 98.0% |
Buy |
| ChemScene CS-0078393 | 1mg | $574 | Pazopanib-d6 98.0% |
Buy |
| AK Scientific 3396DH | 1mg | $710 | 2-Methyl-5-[[4-[[3-methyl-2-(trideuteriomethyl)indazol-6-yl]-(trideuteriomethyl)amino]pyrimidin-2-yl]amino]benzenesulfonamide |
Buy |
Pazopanib-d6 Chemical Properties,Usage,Production
Description
Pazopanib-d6 is intended for use as an internal standard for the quantification of pazopanib by GC- or LC-MS. Pazopanib is a multi-kinase inhibitor that inhibits the VEGF receptors VEGFR1, VEGFR2, and VEGFR3 (IC50s = 10, 30, and 47 nM, respectively, in a cell-free enzyme assay).1 It also inhibits PDGFRα, PDGFRβ, and c-Kit (IC50s = 71, 84, and 74 nM, respectively, in a cell-free enzyme assay) as well as additional receptor tyrosine kinases. Pazopanib inhibits upregulation of the surface adhesion proteins ICAM-1 and VCAM-1 induced by VEGF in multiple myeloma cells cocultured with human umbilical vein endothelial cells (HUVECs) and decreases multiple myeloma cell adhesion to HUVECs.2 It also inhibits proliferation of multiple myeloma cells cocultured with HUVECs. Pazopanib (30 and 100 mg/kg) reduces tumor growth, induces apoptosis, decreases angiogenesis, and increases survival in a multiple myeloma mouse xenograft model. Formulations containing pazopanib have been used in the treatment of cancer.Uses
Pazopanib-d6 is the deuterium labeled Pazopanib. Pazopanib (GW786034) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, FGFR1, and c-Fms with IC50s of 10, 30, 47, 84, 74, 140 and 146 nM, respectively.References
1. Kumar, R., Knick, V.B., Rudolph, S.K., et al. Pharmacokinetic-2. Podar, K., Tonon, G., Satler, M., et al. The small-
Preparation Products And Raw materials
Pazopanib-d6 Suppliers
Global(24)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| 0755-66853366 13670046396 |
orders@qcsrm.com | China | 18188 | 56 | |
| 18108108965 18108108965 |
sales@artisbio.com | China | 2551 | 58 | |
| 400-9205774 400-920-5774 |
sales@glpbio.cn | China | 6705 | 58 | |
| 18818260767 | sales@chemegen.com | China | 11123 | 58 | |
| nanfengpharma@126.co 13127117265 |
nanfengpharma@126.com | China | 19995 | 58 | |
| 020-36607679 13502246435 |
sales@dmstandards.com | China | 10922 | 58 | |
| 4008200310 15002144251 |
marketing@tsbiochem.com | China | 24951 | 58 | |
| 15921286451; 15921286451 |
2010681527@qq.com | China | 4923 | 58 | |
| 17717235263 | offer.de@lgcgroup.com | China | 19035 | 58 | |
| 02151600108 13062666369 |
info@isotopechem.com | China | 4721 | 58 |
1219592-01-4, Pazopanib-d6Related Search
- 1,3-DiMethyl-6-aMino-1H-indazole
- N-(2-Chloropyrimidin-4-YL)-2,3-dimethyl-2H-indazol-6-amine
- Pazopanib Impurity 9
- N-(2-chloropyriMidin-4-yl)-N,2,3-triMethyl-2H-indazol-6-aMine
- 3-Amino-4-methylbenzenesulfonamide
- 5-Amino-2-methylbenzenesulfonamide
- 2-Ethyl-5-nitrobenzenamine ,98%
- 3-Methyl-6-nitroindazole
- 2,3-dimethyl-2H-indazol-6-amine hydrochloride
- 4(1H)-Pyrimidinone, 2-chloro- (9CI)
1of4
PROMPT×
PROMPT
The WhatsApp is temporarily not supported in mainland China
The WhatsApp is temporarily not supported in mainland China
Cancel
Determine